Zanidatamab
jazz,zymeworks
['zymeworks', 'jazz']
together with our partner , we are pleased to share results presented today during #asco23 from a phase 2b clinical trial investigating a #her2-targeted bispecific antibody in previously treated her2-amplified biliary tract cancers. details: 
We’re on a mission to bring patients home to their loved ones, disease free.